Institute of Basic Medicine, Zhejiang Academy of Traditional Chinese Medicine, Zhejiang 310007, P.R. China.
Zhejiang Supor Nanyang pharmaceutical Company Limited, Zhejiang 310017, P.R. China.
Comb Chem High Throughput Screen. 2022;25(9):1534-1544. doi: 10.2174/1386207324666210811142312.
Kuan Xiong aerosol (KXA) is a Chinese herbal compound used to regulate qi-flowing to relieve pain and improve angina. However, only a few pharmacological studies on this traditional Chinese medicine preparation have been reported to confirm these activities.
This article aims to observe the effect of resisting acute myocardial ischemia (AMI) in vivo and dilating vessel in vitro of KXA.
The AMI model involves intravenously injecting the pituitary (2 U.kg) into the ear of rabbits. Electrocardiograph (ECG) T waves were then recorded after administration, and the falling range was calculated. Following this, the level of serum Cardiac troponin T (cTn-T) and the histopathology of the cardiac muscle tissue were evaluated. In vitro, the effect of KXA on vasodilation of isolated aortic rings that had been pre-contracted with KCl (30 mM) was observed.
It was found that KXA reduced ECG ST-T waves and serum cTn-T in the rabbit AMI model, protecting myocardial tissue from fracturing and loss of myocardial fibers and inhibiting inflammatory cell infiltration, cavitation degeneration, and karyopyknosis of the myocardial matrix. Furthermore, the administration of 0.215, 1.075, and 2.150 mg.mL of KXA resulted in significant relaxation of the aortic rings at a rate of 69.63 %, 90.14 %, and 118.72 % (p < 0.01) in the untreated ones, and a second shrinkage ratio of 20.17 %, 4.29 %, and 4.54 % (p < 0.01) in the untreated ones, respectively.
These results suggest that KXA protects against AMI, contributes to the dilation of blood vessels, and has long-acting effectiveness.
宽胸气雾剂(KXA)是一种用于调节气行以缓解疼痛和改善心绞痛的中草药复方。然而,仅有少数关于这种中药制剂的药理学研究报道证实了这些活性。
本文旨在观察 KXA 体内抗急性心肌缺血(AMI)和体外扩张血管的作用。
AMI 模型涉及静脉注射垂体(2 U.kg)到兔耳。给药后记录心电图(ECG)T 波,计算下降幅度。随后,评估血清肌钙蛋白 T(cTn-T)水平和心肌组织的组织病理学。在体外,观察 KXA 对预先用 KCl(30 mM)收缩的分离主动脉环的血管舒张作用。
发现 KXA 减少了兔 AMI 模型中的 ECG ST-T 波和血清 cTn-T,保护心肌组织免受破裂和心肌纤维丢失,并抑制炎症细胞浸润、空泡变性和心肌基质核固缩。此外,给予 0.215、1.075 和 2.150 mg.mL 的 KXA 导致主动脉环的显著松弛率分别为 69.63%、90.14%和 118.72%(p<0.01),未处理组的第二次收缩率分别为 20.17%、4.29%和 4.54%(p<0.01)。
这些结果表明,KXA 对 AMI 具有保护作用,有助于血管扩张,并具有长效作用。